Get the Stockscreener App
2.10
4.98%
-0.11
Co Diagnostics Inc stock is traded at $2.10, with a volume of 126.38K.
It is down -4.98% in the last 24 hours and down -41.18% over the past month.
Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
See More
Previous Close:
$2.21
Open:
$2.23
24h Volume:
126.38K
Relative Volume:
0.02
Market Cap:
$7.74M
Revenue:
$513.90K
Net Income/Loss:
$-48.50M
P/E Ratio:
-0.075
EPS:
-28.0101
Net Cash Flow:
$-28.99M
1W Performance:
-14.63%
1M Performance:
-41.18%
6M Performance:
-64.22%
1Y Performance:
-87.42%
1-Day Range:
$2.06
$2.27
1-Week Range:
$2.06
$2.6088
52-Week Range:
$1.26
$13.54
Co Diagnostics Inc Stock (CODX) Company Profile
Name
Co Diagnostics Inc
Sector
Industry
Phone
(801) 438-1036
Address
2401 S FOOTHILL DRIVE, SALT LAKE CITY
Compare CODX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
2.10 | 7.74M | 513.90K | -48.50M | -28.99M | -28.01 |
ABT
Abbott Laboratories
|
103.06 | 179.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
330.25 | 126.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.21 | 106.51B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
44.25 | 65.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.63 | 47.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-22 | Downgrade | Sidoti | Buy → Neutral |
| Dec-29-21 | Initiated | Sidoti | Buy |
| Mar-29-21 | Downgrade | Maxim Group | Buy → Hold |
| May-20-20 | Upgrade | Maxim Group | Hold → Buy |
| May-18-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-09-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-03-20 | Downgrade | Maxim Group | Buy → Hold |
View All
Co Diagnostics Inc Stock (CODX) Latest News
CODX Stock Explodes Over 630% In Six Sessions – Retail Traders Bet The Rally Isn’t Over Yet - Stocktwits
CODX: Co-Diagnostics Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Co-diagnostics Company Profile & Introduction - Moomoo
Co-Diagnostics launches TB test clinical trials on PCR Pro devices in India labs - Pluang
Co-Diagnostics joint venture begins TB test clinical studies in India - Investing.com
About 30-Minute TB Test Enters Evaluation in Indian Labs - Stock Titan
EXCLUSIVE: Co-Diagnostics Marks New Milestone as India TB Test Clinical Studies Begin - Yahoo Finance
Form DEF 14A CO-DIAGNOSTICS For: 21 July By Investing.com - Investing.com Nigeria
$2.45 | Co-Diagnostics, Inc. Common Stock (CODX) Stock Price Today - Binance
Co-diagnostics(CODX) Stock Options Chain | Quotes & News - Moomoo
CODX Stock Price, Quote & Chart - ChartMill
Co-Diagnostics names Wes Lindsey as chief scientific officer - Investing.com India
Why Did CODX Stock Nearly Double In Value Today? - Stocktwits
Co-Diagnostics names Wes Lindsey as chief scientific officer By Investing.com - Investing.com South Africa
Co-Diagnostics Appoints Wes Lindsey, PhD, MBA as Chief Scientific Officer - Finviz
Co-Diagnostics Names New Chief; Co-Dx PCR Is Not Yet for Sale - Stock Titan
Co-Diagnostics names Wes Lindsey chief scientific officer - Bitget
Form PRE 14A CO-DIAGNOSTICS For: 10 July By Investing.com - Investing.com South Africa
Co‑Diagnostics seeks shareholder approval to add 2.0M shares to equity plan | CODX SEC FilingForm PRE 14A - Stock Titan
Co-Diagnostics to show TB test platform at UN workshop in Bangkok - Stock Titan
Why did CODX stock surge 45% in pre-market today? - MSN
OpenAI's Major Overhaul: Aiming for Growth Before IPO - GuruFocus
CO-DIAGNOSTICS INC (CODX) Stock Chart - ChartMill
CODX Q1 2026 Earnings: EPS Misses Estimates as Revenue Remains AbsentNegative Surprise Momentum - dars.gov.et
Co-Diagnostics completes studies for FDA test submission By Investing.com - Investing.com Nigeria
Co-Diagnostics completes studies for FDA test submission - Investing.com
Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test - PR Newswire
EXCLUSIVE: Co-Diagnostics Reaches Regulatory Milestone for PCR Respiratory Test Platform - Yahoo Finance
Price to earnings forward of Co-Diagnostics, Inc. – NASDAQ:CODX - TradingView
Price to earnings forward of Co-Diagnostics, Inc. – LSE:0A50 - TradingView
Enterprise value to revenue forward of Co-Diagnostics, Inc. – NASDAQ:CODX - TradingView
Price to sales forward of Co-Diagnostics, Inc. – NASDAQ:CODX - TradingView
Price to book forward of Co-Diagnostics, Inc. – NASDAQ:CODX - TradingView
Enterprise value to EBITDA forward of Co-Diagnostics, Inc. – NASDAQ:CODX - TradingView
Price to sales forward of Co-Diagnostics, Inc. – LSE:0A50 - TradingView
Co-Diagnostics jumps 11%, raises $3M privately - MSN
Co-Diagnostics expands mosquito testing services to 21 states By Investing.com - Investing.com Australia
Co Diagnostics Inc Stock (CODX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.90%
2.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):